DK0657161T3 - Farmaceutisk granulat indeholdende steroider - Google Patents

Farmaceutisk granulat indeholdende steroider

Info

Publication number
DK0657161T3
DK0657161T3 DK93203476T DK93203476T DK0657161T3 DK 0657161 T3 DK0657161 T3 DK 0657161T3 DK 93203476 T DK93203476 T DK 93203476T DK 93203476 T DK93203476 T DK 93203476T DK 0657161 T3 DK0657161 T3 DK 0657161T3
Authority
DK
Denmark
Prior art keywords
carrier
mixture
optionally
granules
desogestrel
Prior art date
Application number
DK93203476T
Other languages
Danish (da)
English (en)
Inventor
Jan Hendrik Dopper
Der Ven Cornelis Josephus Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27578967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0657161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0657161T3 publication Critical patent/DK0657161T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK93203476T 1992-09-04 1993-12-10 Farmaceutisk granulat indeholdende steroider DK0657161T3 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US07/941,026 US5395627A (en) 1992-09-04 1992-09-04 Pharmaceutical granulate
EP93203476A EP0657161B1 (fr) 1992-09-04 1993-12-10 Granules pharmaceutiques contenant des steroides
FI935584A FI111221B (fi) 1992-09-04 1993-12-13 Menetelmä farmaseuttisten rakeiden valmistamiseksi
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett
CA002111320A CA2111320A1 (fr) 1992-09-04 1993-12-13 Granules pharmaceutiques
NZ250443A NZ250443A (en) 1992-09-04 1993-12-13 Preparation of film coated, steroid-loaded granules
ZA939337A ZA939337B (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
AU52391/93A AU672447B2 (en) 1992-09-04 1993-12-14 Pharmaceutical granulate
JP32229093A JP3720385B2 (ja) 1992-09-04 1993-12-21 医薬顆粒
CN93121510A CN1050043C (zh) 1992-09-04 1993-12-29 药物颗粒

Publications (1)

Publication Number Publication Date
DK0657161T3 true DK0657161T3 (da) 1999-08-16

Family

ID=27578967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93203476T DK0657161T3 (da) 1992-09-04 1993-12-10 Farmaceutisk granulat indeholdende steroider

Country Status (15)

Country Link
US (2) US5395627A (fr)
EP (1) EP0657161B1 (fr)
JP (1) JP3720385B2 (fr)
CN (1) CN1050043C (fr)
AT (1) ATE173918T1 (fr)
AU (1) AU672447B2 (fr)
CA (1) CA2111320A1 (fr)
DE (1) DE69322396T2 (fr)
DK (1) DK0657161T3 (fr)
ES (1) ES2125300T3 (fr)
FI (1) FI111221B (fr)
GR (1) GR3029273T3 (fr)
NO (1) NO306928B1 (fr)
NZ (1) NZ250443A (fr)
ZA (1) ZA939337B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
IL113816A (en) † 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
RU2159618C2 (ru) * 1995-06-22 2000-11-27 Акцо Нобель Н.В. Прессованные таблетки дезогестрела, изготовленные способом сухого гранулирования
WO1997004752A1 (fr) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Compositions pharmaceutiques d'oestrogenes conjugues et leurs modes d'emploi
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
DE69702985T2 (de) 1997-09-23 2001-02-15 Akzo Nobel Nv Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
DE60139087D1 (de) * 2000-12-14 2009-08-06 Ortho Mcneil Janssen Pharm Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
ATE243028T1 (de) * 2001-07-11 2003-07-15 Applied Pharma Res Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
EP1853272A1 (fr) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
US20070248665A1 (en) * 2006-04-24 2007-10-25 Sherman Bernard C Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
US10952968B2 (en) * 2012-05-14 2021-03-23 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CN103271927A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进口服避孕药含量均匀性三级稀释法的工艺
CN103271928A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进去氧孕烯稳定性的处方工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
AU672447B2 (en) 1996-10-03
ES2125300T3 (es) 1999-03-01
DE69322396T2 (de) 1999-07-29
NO306928B1 (no) 2000-01-17
AU5239193A (en) 1995-07-13
CN1104487A (zh) 1995-07-05
NZ250443A (en) 1995-07-26
JP3720385B2 (ja) 2005-11-24
NO934584L (no) 1995-06-14
EP0657161A1 (fr) 1995-06-14
CN1050043C (zh) 2000-03-08
ZA939337B (en) 1994-10-13
CA2111320A1 (fr) 1995-06-14
US5527543A (en) 1996-06-18
NO934584D0 (no) 1993-12-13
FI935584A (fi) 1995-06-14
GR3029273T3 (en) 1999-05-28
FI111221B (fi) 2003-06-30
JPH07196513A (ja) 1995-08-01
DE69322396D1 (de) 1999-01-14
FI935584A0 (fi) 1993-12-13
US5395627A (en) 1995-03-07
ATE173918T1 (de) 1998-12-15
EP0657161B1 (fr) 1998-12-02

Similar Documents

Publication Publication Date Title
DK0657161T3 (da) Farmaceutisk granulat indeholdende steroider
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
KR880001237B1 (ko) 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법
EP0583578A3 (en) 17-(3-furyl) and 17-(4-pyridazinyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
EP0159777A1 (fr) 4-Carbamoyl-imidazolium-5-stabilisé
HRP20000291B1 (en) High purity (1r, 2s, 4r)-(-)-2-/(2'-/n,n-dimethylamino/-ethoxy)/-2-/phenyl/-1,7,7-tri-/methyl/bicyclo/2.2.1/ heptane and pharmaceutically acceptable acid addition salts thereof and process for the preparation of these compounds as well medicaments containing one or more of them and the use thereof
DE60031557D1 (de) Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
JPS57183777A (en) Preparation of mycophenolic acid derivative
EP0401894B1 (fr) Composition de cyclophosphamide lyophylisée pulvérulente et son procédé de préparation
US3133858A (en) Stable thiobarbituric acid solution
KR950016749A (ko) 약제용 과립 및 그 제조 방법
AU1895483A (en) Mg/zn diketonate complexes adducted with thf
JPH03502792A (ja) ミノキシジルゲル
JPS55111470A (en) Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
Cunico et al. A Phenylcarbene Transfer System
ATE30712T1 (de) 4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
TH14841EX (th) แกรนูลยา
JPS5655362A (en) Polyfunctional azide compound and its preparation
TH13833EX (th) สารประกอบ
JPS5626832A (en) Preparation of cyclopentenolone
JPH04178303A (ja) 安定な農薬組成物
JPS54125651A (en) Monocyclic beta-lactam derivative and its preparation